We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
First quarter results 2025
April 29, 2025 | Basel, Switzerland
Media release: English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB)
Interim financial report (PDF 0.3 MB)
Watch the webcast
Download the podcast (MP3 32 MB)
Download the presentation (PDF 3.7 MB)
Download 2025 epidemiology data (PDF 2.0 MB)
Novartis Q1 2025 impact and sustainability update (PDF 0.9 MB)
Investors event calendar
View recent presentations and learn more about upcoming events.
May 28, 2025
Bernstein Annual Strategic Decisions
New York, USA
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: May 2025 (PDF 0.9 MB) | February 2025 (PDF 1.0 MB) | October 2024 (PDF 0.6 MB) | July 2024 (PDF 0.9 MB)
Latest updates: Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.
Stocks